NewAmsterdam Pharma Company Stock (NAMS)
Track NewAmsterdam Pharma Company stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
NAMS
NewAmsterdam Pharma Company
healthcare
$35.40
▲ +19.55 (+114.93%) past year
Market Cap
$4.22B
P/E Ratio
—
1Y Return
+114.93%
EPS (TTM)
-$1.80
Read the latest TheStreet Pro articles mentioning NewAmsterdam Pharma Company, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning NAMS yet.
Daily Diary Mentions
0 mentionsNo diary mentions for NAMS yet.